teva pharmaceuticals introduces the first generic glp-1 for weight loss Saxenda Teva Pharmaceutical Industries (TEVA) Announces
Description
Semaglutide represents an important advance in the pediatric obesity management, with clear short-term reductions in BMI and improvement in metabolic parameters
"Sometimes these knockoff medicines which come from places like China and India are sold by entities that cannot even legally sell them in their own countries," said Patrik Jonsson, president of Lily USA.
Batch-specific Certificates of Analysis improve traceability and allow researchers to verify that analytical results correspond to the exact material received
Their integrated care model ensures optimal drug safety and efficacy for high-risk patients
